Search
for
Sort by
Research 751–780 of 1000+
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Management of Toxicities of Targeted Therapies
- Dermatological drugs, topical agents, and cosmetics
- Nutritional Management of Menopausal Women
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Cutaneous reactions to recombinant cytokine therapy
- Toxic Epidermal Necrolysis
- Redefining hormone resistance in prostate cancer
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Subject Index
- MINOXIDIL FOR MALE-PATTERN BALDNESS
- Cutaneous Blood Flow.
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Is dehydroepiandrosterone a hormone?
- A role for p75 neurotrophin receptor in the control of apoptosis‐driven hair follicle regression
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Hair Biology and Nutritional Influences
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Teriflunomide in multiple sclerosis: an update
- Ottawa, Ontario, Canada, February 13–16, 2013
- Healthy Skin for Women: A Review of Common Conditions and Therapies